Literature DB >> 27492455

MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene.

Christopher Alderman1, Ayoub Sehlaoui1, Zhaoyang Xiao2, Yixin Yang3.   

Abstract

MicroRNAs can affect behaviors of tumor cells by modulating the expression of the target genes that involve tumor growth, invasiveness, and death. The goal of this research is to examine the effects of miR-15a on the proliferation and invasiveness of malignant melanoma cells in vitro, as well as the therapeutic effect of miR-15a in a mouse melanoma model. miR-15a displayed inhibitory effects on proliferation and invasiveness of several malignant melanoma cell lines. miR-15a also caused cell cycle arrest at G1/G0 phase. miRNA 15a downregulated the expressions of CDCA4 and AKT-3 in melanoma cell lines. In vivo, experiment showed that miRNA 15a significantly retarded the growth of melanoma tumors in the mouse model. The luciferase reporter assay demonstrated that miR15a can suppress gene expression through the binding site in the 3 'UTR of CACD4, which is a bona fide target of miRNA 15a. In conclusion, miRNA 15a suppressed the growth and invasiveness of melanoma cells, suggesting that miRNA 15a may represent a viable microRNA-based therapy against melanoma.

Entities:  

Keywords:  AKT3; CDCA4; Cell cycle; Invasion; Melanoma; miR-15a

Mesh:

Substances:

Year:  2016        PMID: 27492455     DOI: 10.1007/s13277-016-5271-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  48 in total

1.  Improved survival with MEK inhibition in BRAF-mutated melanoma.

Authors:  Keith T Flaherty; Caroline Robert; Peter Hersey; Paul Nathan; Claus Garbe; Mohammed Milhem; Lev V Demidov; Jessica C Hassel; Piotr Rutkowski; Peter Mohr; Reinhard Dummer; Uwe Trefzer; James M G Larkin; Jochen Utikal; Brigitte Dreno; Marta Nyakas; Mark R Middleton; Jürgen C Becker; Michelle Casey; Laurie J Sherman; Frank S Wu; Daniele Ouellet; Anne-Marie Martin; Kiran Patel; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2012-06-04       Impact factor: 91.245

2.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR.

Authors:  J Robin Lytle; Therese A Yario; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

3.  Modelling population-based cancer survival trends using join point models for grouped survival data.

Authors:  Binbing Yu; Lan Huang; Ram C Tiwari; Eric J Feuer; Karen A Johnson
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-04       Impact factor: 2.483

Review 4.  The role of microRNAs in melanoma.

Authors:  Chonglin Luo; Claudia E M Weber; Wolfram Osen; Anja-Katrin Bosserhoff; Stefan B Eichmüller
Journal:  Eur J Cell Biol       Date:  2014-02-11       Impact factor: 4.492

5.  Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Authors:  Mitchell Cheung; Arati Sharma; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.

Authors:  Daniel W Mueller; Michael Rehli; Anja K Bosserhoff
Journal:  J Invest Dermatol       Date:  2009-02-12       Impact factor: 8.551

7.  MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-γ.

Authors:  Ping Li; Xiao-Bing Xie; Qian Chen; Guo-Lian Pang; Wan Luo; Jian-Cheng Tu; Fang Zheng; Song-Mei Liu; Lu Han; Jian-Kun Zhang; Xian-Yong Luo; Xin Zhou
Journal:  Asian Pac J Cancer Prev       Date:  2014

8.  MicroRNA-dependent regulation of cKit in cutaneous melanoma.

Authors:  O Igoucheva; V Alexeev
Journal:  Biochem Biophys Res Commun       Date:  2009-01-04       Impact factor: 3.575

9.  MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.

Authors:  Xu Tian; Jian Zhang; Liang Yan; Jing-Ming Dong; Qiang Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.

Authors:  Wang Renjie; Liang Haiqian
Journal:  Cancer Lett       Date:  2014-10-08       Impact factor: 8.679

View more
  18 in total

1.  miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.

Authors:  Christos K Kontos; Panagiotis Tsiakanikas; Margaritis Avgeris; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.

Authors:  Yulian Mytsyk; Yuriy Borys; Lesia Tumanovska; Dmytro Stroy; Askold Kucher; Katarina Gazdikova; Luis Rodrigo; Peter Kruzliak; Robert Prosecky; Peter Urdzik; Victor Dosenko
Journal:  Clin Exp Med       Date:  2019-08-22       Impact factor: 3.984

3.  Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.

Authors:  Amirhossein Fathinavid; Mohadeseh Zarei Ghobadi; Ali Najafi; Ali Masoudi-Nejad
Journal:  BMC Genom Data       Date:  2021-10-12

Review 4.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

5.  Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma.

Authors:  Zhongqing Li; Lanting Liu; Chenxing Du; Zhen Yu; Yuanyuan Yang; Jie Xu; Xiaojing Wei; Fenghuang Zhan; Yongrong Lai; Lugui Qiu; Mu Hao
Journal:  Cancer Gene Ther       Date:  2020-01-28       Impact factor: 5.987

6.  The roles of the cell division cycle-associated gene family in hepatocellular carcinoma.

Authors:  Qiang Tao; Siliang Chen; Jia Liu; Peng Zhao; Lingmin Jiang; Xinyue Tu; Xiang Tang; Zonghao Liu; Abudoukeyimu Yasheng; Kahaer Tuerxun; Yun Zheng
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 7.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

8.  Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.

Authors:  Gang Li; Tie Chong; Xiaolong Xiang; Jie Yang; Hongliang Li
Journal:  Oncol Rep       Date:  2017-08-11       Impact factor: 3.906

9.  The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p.

Authors:  Christopher Alderman; Yixin Yang
Journal:  RNA Dis       Date:  2016-11-14

10.  CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF‑7/ADM human breast cancer cell line.

Authors:  Yuju Xu; Xianghua Wu; Fengxi Li; Daolai Huang; Wenxiang Zhu
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.